WebMD Health Corp., an Internet Brands company and a leader in health information services for consumers and healthcare professionals (HCPs), today announced the acquisition of ADDitude, a multi-channel platform supporting people with attention deficit hyperactivity disorder (ADHD), their caregivers, and professionals in the ADHD treatment space.
The acquisition builds upon WebMD’s leadership in empowering consumers and patients with the best-in-class conditions and disease-focused content and resources to help them take action for their health. The acquisition also leverages WebMD’s broad reach and engagement with health-seeking communities through a targeted platform that addresses one of the most common neurodevelopmental disorders in the U.S.
Based in New York, ADDitude is the leading source of ADHD information and resources, consulted more than 75 million times annually for trusted, evidence-based information from leading medical experts. ADDitude features a rich set of features, news, and interactive tools, including ADDitude symptom tests; information for parents, adults, HCPs, and educators; an ADHD Experts Program of webinars, videos, and podcasts; an “Ask the Expert” column; a professional resource directory; and a quarterly magazine.
“ADDitude and WebMD share a core mission to empower patients with a digital health information platform that can improve and enhance their lives,” said WebMD and Internet Brands CEO Bob Brisco. “With the acquisition, WebMD can leverage its reach and scale to support the work of ADDitude, accelerate engagement with this growing patient population, and increase opportunities for customers that serve patients with ADHD.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“We are excited to join forces with WebMD to accelerate our commitment to people living with ADHD,” said Susan Caughman, Founder, and CEO, ADDitude. “More than 6 million U.S. children and nearly 3 million adults are known to have ADHD, and the incidence is growing annually. With WebMD, we can broaden our impact and touch even more patients, caregivers, and professionals with trusted information and innovative resources.”
Terms of the acquisition are not being disclosed.
Source: Biospace